MesencHyal-T

Junin, Argentina

MesencHyal-T is a biotechnology company that develops cellular medical therapies for the treatment of tissue regeneration.

$250K raised

Jan 2024

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MesencHyal-T raised?

MesencHyal-T has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.

Who are MesencHyal-T's investors?

MesencHyal-T's investors include SF500.

Where is MesencHyal-T headquartered?

MesencHyal-T is headquartered in Junin, Argentina.

What does MesencHyal-T do?

MesencHyal-T is a biotechnology company that develops cellular medical therapies for the treatment of tissue regeneration.

What stage is MesencHyal-T at?

MesencHyal-T is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2024.

MLA

"MesencHyal-T — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/mesenchyal-t. Accessed July 2, 2026.

APA

VCBacked. (2024). MesencHyal-T — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mesenchyal-t

Wikipedia (cite web)

{{cite web |title=MesencHyal-T — Funding & Investors |url=https://www.vcbacked.co/company/mesenchyal-t |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2024.